coronavirus
#COVID-19 - Research package welcomed, EU needs to be better equipped in future

Published
1 year agoon


"We applaud the measures taken by Commissioner Gabriel and the pooling of almost €140 million against COVID 19. The Commission was very fast in launching a special call for expressions of interest from Horizon 2020 and involving relevant stakeholders under the Innovative Medicines Initiative (IMI) public-private partnership", said Horizon Europe rapporteur Christian Ehler (EPP, DE).
"Now, we have to start thinking ahead in order to be better equipped for the future. Research and development clearly have an important role to play in addressing global challenges. This is yet another reason to support our proposal for €120 billion for Horizon Europe," he added.
A test of our ability to work together
"The health crisis posed by COVID-19 is focusing minds. The top priority now is to stem the spread of the virus. Behind the scenes, emergency research is working on finding a treatment and a vaccine. The virus’ extraordinary rate of contagion should make us aware that our interconnected world has shrunk considerably and that joint and coordinated action between states is the only way to deal with this crisis," said Christian Ehler.
"This crisis is a test of our ability to work together on an emergency situation on the one hand, and to remain faithful to our long-term objectives on the other," he said.
"When this crisis is over, we must immediately prepare for the next one. This means investing more in research and ensuring that programmes such as Horizon Europe do not become hostages to short-term squabbles between member states," he concluded.
COVID-19: EU and industry to fund more research through Innovative Medicines Initiative
The Innovative Medicines Initiative (IMI), a public-private partnership between the European Commission and the pharmaceutical industry, has today launched a fast-track call for research proposals to develop treatments and diagnostics in response to the COVID-19 outbreak. Up to €45 million of the funding will come from Horizon 2020, the EU research and innovation programme.
This call is part of the co-ordinated EU response to the public health threat of COVID-19 and complements the emergency research funding already mobilized recently under Horizon 2020. You can find more information about the IMI call here, and the EU research actions on COVID-19 here.
You may like
-
Germany wants to use Regeneron's COVID-19 antibody therapy more broadly
-
European powers warn Iran over 'dangerous' uranium enrichment move
-
President von der Leyen on developments in the Vaccines Strategy
-
Coronavirus response: Commission proposes to exempt vital goods and services distributed by the EU from VAT in times of crisis
-
Merkel defends stricter lockdown powers as key to beating pandemic
-
France suspends all flights to and from Brazil due to COVID variant
coronavirus
Germany wants to use Regeneron's COVID-19 antibody therapy more broadly

Published
22 hours agoon
April 16, 2021By
Reuters
Germany would like to use Regeneron’s COVID-19 monoclonal antibody cocktail as a treatment for this disease more broadly but needs to finalize some details on reimbursement, Health Minister Jens Spahn said on Thursday (15 April), writes Caroline Copley.
“The drug is available in Germany, we need it much more and we want it much more and we are working on rolling it out across the nation,” he told a weekly news conference.
coronavirus
President von der Leyen on developments in the Vaccines Strategy

Published
2 days agoon
April 15, 2021
In a press statement on 14 April, President of the European Commission, Ursula von der Leyen, announced an agreement with BioNTech-Pfizer to accelerate the delivery of 50 million vaccine doses to the second quarter of this year, starting this month: “We are in a race against time. The faster we reach our target of having 70% of adults in the European Union vaccinated, the better chances we have of containing the virus. And the good news is: Vaccination is picking up speed across Europe! Member states have received over 126 million doses of vaccines as of yesterday (13 April). And I am happy to say that today we have reached 100 million vaccinations in the EU. This is a milestone that we can be proud of. Of these 100 million vaccinations, more than a quarter are second doses – which means that we have now more than 27 million people fully vaccinated I am pleased to announce that we have reached an agreement with BioNTech-Pfizer to, once again, speed up the delivery of vaccines. 50 million additional doses of BioNTech-Pfizer vaccines will be delivered in quarter 2 of this year, starting in April. This will bring the total doses delivered by BioNTech-Pfizer to 250 million doses in the second quarter. These doses will be distributed pro-rata to the population, among all the member states. This will substantially help consolidate the roll-out of our vaccination campaigns.” As part of preparations for the medium term, the Commission is also entering into a negotiation with BioNTech-Pfizer for a third contract, to foresee the delivery of 1.8 billion doses of vaccine over the period of 2021 to 2023. This contract will entail that not only the production of the vaccines, but also all essential components, will be based in the EU. The President's full statement is available online in English, and French and shortly in German. You can watch it here.
coronavirus
Coronavirus response: Commission proposes to exempt vital goods and services distributed by the EU from VAT in times of crisis

Published
3 days agoon
April 14, 2021
The European Commission has proposed to exempt from Value Added Tax (VAT) goods and services made available by the European Commission, EU bodies and agencies to Member States and citizens during times of crisis. This responds to the experience gained during the course of the Coronavirus pandemic. Among other things, it has shown that the VAT charged on some transactions ends up being a cost factor in procurement operations that strains limited budgets. Therefore, today'sinitiative will maximise the efficiency of EU funds used in the public interest to respond to crises, such as natural disasters and public health emergencies. It will also strengthen EU-level disaster and crisis management bodies, such as those falling under the EU's Health Union and the EU Civil Protection Mechanism.
Once in place, the new measures will allow the Commission and other EU agencies and bodies to import and purchase goods and services VAT-free when those purchases are being distributed during an emergency response in the EU. The recipients might be Member States or third parties, such as national authorities or institutions (for example, a hospital, a national health or disaster response authority). Goods and services covered under the proposed exemption include, for instance:
- Diagnostic tests and testing materials, and laboratory equipment;
- personal protective equipment (PPE) like gloves, respirators, masks, gowns, disinfection products and equipment;
- tents, camp beds, clothing and food;
- search and rescue equipment, sandbags, life jackets and inflatable boats;
- antimicrobials and antibiotics, chemical threat antidotes, treatments for radiation injury, antitoxins, iodine tablets;
- blood products or antibodies;
- radiation measuring devices, and;
- development, production and procurement of necessary products, research and innovation activities, strategic stockpiling of products; pharmaceutical licences, quarantine facilities, clinical trials, disinfection of premises, etc.
Economy Commissioner Paolo Gentiloni said: “The COVID-19 pandemic has taught us that these kinds of crises are multifaceted and have a wide-ranging impact on our societies. A rapid and efficient response is essential, and we need to provide the best response now in order to prepare for the future. Today's proposal supports the EU's goal to react to crises and emergencies in the EU. It will also ensure that the financial impact of EU-level relief efforts to fight the pandemic and support the recovery is maximized.”
Next steps
The legislative proposal, which will amend the VAT directive, will now be submitted to the European Parliament for its opinion, and to the Council for adoption.
Member States shall adopt and publish, by 30 April 2021 the laws regulations and administrative provisions necessary to comply with this Directive. They shall apply those measures from 1 January 2021.
Background
The Coronavirus pandemic has thrown into sharp light the importance of coherent, decisive and centralised EU-level preparation and response in times of crisis. In the context of the Coronavirus pandemic, the von der Leyen Commission has already outlined plans to strengthen EU preparedness and management for cross-border health threats, and presented the building blocks of a stronger European Health Union. At the same time, the Commission has proposed to strengthen cooperation between EU Member States through the EU Civil Protection Mechanism with the aim of improving responses to future natural or man-made disasters. For instance, in the context of the new European Health Union, the Commission announced the creation of the Health Emergency Response Authority (HERA) to deploy rapidly the most advanced medical and other measures in the event of a health emergency, by covering the whole value chain from conception to distribution and use.
The EU has already taken action in the field of taxation and customs to support the fight against and the recovery from the coronavirus pandemic. In April 2020, the EU agreed to waive customs and VAT charges for imports of masks and other protective equipment needed to fight the pandemic. This waiver remains in place and plans are underway for its extension. In December 2020, EU member states agreed on new measures proposed by the Commission to allow a temporary VAT exemption for vaccines and testing kits being sold to hospitals, doctors and individuals, as well as closely related services. Under the amended Directive, member states can apply either reduced or zero rates to both vaccines and testing kits if they so choose.
More information
Commission proposes to exempt vital goods and services distributed by the EU in times of crisis
COVID-19 response in the field of taxation and customs
Trending
-
Mongolia3 days ago
The Mongolian connection to Lukashenko’s money
-
Serbia5 days ago
Rio Tinto’s gung-ho mining exploration on the border of the European Union should worry us all
-
Brexit3 days ago
MEPs delay Brexit trade vote until UK respects withdrawal agreement
-
coronavirus5 days ago
French coronavirus intensive care cases and deaths keep rising
-
EU5 days ago
Commission opens first European Innovation Council calls worth €1 billion
-
European Commission4 days ago
Victor Shokin files complaint with European Commission over 2016 firing
-
Caribbean4 days ago
The imperative of foreign direct investment for Caribbean countries
-
Kazakhstan3 days ago
Kazakhstan’s government determined to enhance engagement with civil society